Cargando…

Dipyridamole with Low-Dose Aspirin Augments the Infarct Size-Limiting Effects of Simvastatin

PURPOSE: Statins protect against ischemia-reperfusion injury and limit myocardial infarct size (IS). This effect is dependent on increased generation of adenosine by ecto-5′ nucleotidase and downstream activation of cyclooxygenase-2 (COX2). Dipyridamole (DIP) augments the IS-limiting effects of stat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Yumei, Long, Bo, Qian, Jinqiao, Perez-Polo, Jose R., Birnbaum, Yochai
Formato:	Texto
Lenguaje:	English
Publicado:	Springer US 2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3051102/ https://www.ncbi.nlm.nih.gov/pubmed/20640495 http://dx.doi.org/10.1007/s10557-010-6252-x

Ejemplares similares

Dipeptidyl peptidase-4 inhibition by Saxagliptin prevents inflammation and renal injury by targeting the Nlrp3/ASC inflammasome
por: Birnbaum, Yochai, et al.
Publicado: (2016)

Comparative evaluation of treatment with low-dose aspirin plus dipyridamole versus aspirin only in patients with acute ischaemic stroke
por: Arnarsdottir, Lola, et al.
Publicado: (2012)

Aleglitazar, a dual peroxisome proliferator-activated receptor-α and -γ agonist, protects cardiomyocytes against the adverse effects of hyperglycaemia
por: Chen, Yan, et al.
Publicado: (2017)

Dipyridamole augments the antiinflammatory response during human endotoxemia
por: Ramakers, Bart P, et al.
Publicado: (2011)

Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial
por: Bath, Philip M, et al.
Publicado: (2018)

Combination Therapy with Dipyridamole and Clopidogrel for Secondary Stroke Prevention in Aspirin-Intolerant Patients After Myocardial Infarction: Results of a Nationwide Case-Control Study
por: Wang, Mei-Tzu, et al.
Publicado: (2019)

Effect of low dose aspirin and dipyridamole on primary patency of arteriovenous grafts in hemodialysis patients: a randomized double-blind placebo-controlled trial
por: Tayebi, Pouya, et al.
Publicado: (2018)

Somatic Drugs for Psychiatric Diseases: Aspirin or Simvastatin for Depression?
por: Rahola, Juan Gibert
Publicado: (2012)

Why Not Dipyridamole: a Review of Current Guidelines and Re-evaluation of Utility in the Modern Era
por: Allahham, Mahmoud, et al.
Publicado: (2021)

Is there a Future for Remote Ischemic Conditioning in Acute Myocardial Infarction?
por: Stiermaier, Thomas, et al.
Publicado: (2021)

A Randomised Controlled Trial of Triple Antiplatelet Therapy (Aspirin, Clopidogrel and Dipyridamole) in the Secondary Prevention of Stroke: Safety, Tolerability and Feasibility
por: Sprigg, Nikola, et al.
Publicado: (2008)

Dipyridamole ameliorates doxorubicin-induced cardiotoxicity
por: Alyasiry, Esraa, et al.
Publicado: (2022)

Rapid Diagnosis of STEMI Equivalent in Patients With Left Bundle‐Branch Block: Is It Feasible?
por: Birnbaum, Yochai, et al.
Publicado: (2021)

Antiplatelet agents aspirin and dipyridamole, and the risk of different carcinoma in patients with type 2 diabetes mellitus: A Taiwan retrospective cohort study
por: Huang, Hsing-Yi, et al.
Publicado: (2022)

Dipyridamole and vascular healing following stent implantation
por: Simard, Trevor, et al.
Publicado: (2023)

The Dipyridamole Added to Dual Antiplatelet Therapy in Cerebral Infarction After First Acute Myocardial Infarction: A Nationwide, Case-Control Study
por: Wang, Mei-Tzu, et al.
Publicado: (2018)

Aspirin plus dipyridamole has the highest surface under the cumulative ranking curves (SUCRA) values in terms of mortality, intracranial hemorrhage, and adverse event rate among 7 drug therapies in the treatment of cerebral infarction
por: Zhang, Jian-Jun, et al.
Publicado: (2018)

The signal pathway for the repressive effect of dipyridamole on myofibroblast transdifferentiation
por: Yan, Qiong, et al.
Publicado: (2018)

Dipyridamole-induced STEMI: case report and review of the literature
por: Hennawi, Hussam Al, et al.
Publicado: (2023)

Low-Dose Aspirin Augments the Anti-Inflammatory Effects of Low-Dose Lithium in Lipopolysaccharide-Treated Rats
por: Shvartsur, Rachel, et al.
Publicado: (2022)

Dipyridamole modulates the innate immune response during human endotoxemia
por: Ramakers, B, et al.
Publicado: (2011)

Ocular Applications of Dipyridamole: A Review of Indications and Routes of Administration
por: Rogosnitzky, Moshe, et al.
Publicado: (2016)

The possible protective effects of dipyridamole on ischemic reperfusion injury of priapism
por: Karaguzel, Ersagun, et al.
Publicado: (2016)

Assessment of dipyridamole stress echocardiography for risk stratification of diabetic patients
por: Baroncini, Liz Andréa Villela, et al.
Publicado: (2015)

Reduction of microglial activity in a model of multiple sclerosis by dipyridamole
por: Sloka, Scott, et al.
Publicado: (2013)

Unusual Dipyridamole-induced Aberrant Conduction in the Absence of Myocardial Ischemia
por: Ricca-Mallada, Roberto, et al.
Publicado: (2017)

Dipyridamole induces the phosphorylation of CREB to promote cancer cell proliferation
por: Abdelghany, Lina, et al.
Publicado: (2021)

Atrioventricular (AV) block and sinus arrest associated with dipyridamole infusion
por: Khalili, Mahdi, et al.
Publicado: (2022)

Simvastatin augmentation for recent-onset psychotic disorder: A study protocol
por: Begemann, Marieke J.H., et al.
Publicado: (2015)

Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins
por: De Berardis, Giorgia, et al.
Publicado: (2007)

Impact of Antecedent Aspirin Use on Infarct Size, Bleeding and Composite Endpoint in Patients with de Novo Acute Myocardial Infarction
por: Enhos, Asim, et al.
Publicado: (2021)

Does dipyridamole-induced ischaemia affect NT-proBNP secretion?
por: De Greef, Jacques, et al.
Publicado: (2007)

Pterygium: Nonsurgical Treatment Using Topical Dipyridamole – A Case Report
por: Carlock, Beth H., et al.
Publicado: (2014)

Dipyridamole-induced adverse effects in myocardial perfusion scans: Dynamic evaluation
por: Lee, Sin-Di, et al.
Publicado: (2016)

Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19
por: Liu, Xiaoyan, et al.
Publicado: (2020)

Dipyridamole and adenosinergic pathway in Covid-19: a juice or holy grail
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022)

Effect of Dipyridamole on Membrane Energization and Energy Transfer in Chromatophores of Rba. sphaeroides
por: Knox, Peter P., et al.
Publicado: (2022)

Early dipyridamole stress myocardial SPECT to detect residual stenosis of infarct related artery: comparison with coronary angiography and fractional flow reserve.
por: Seo, Jeong Kee, et al.
Publicado: (2002)

Low dose aspirin and pregnancy: how important is aspirin resistance?
por: Navaratnam, K, et al.
Publicado: (2016)

Aspirin induces IL-4 production: augmented IL-4 production in aspirin-exacerbated respiratory disease
por: Kong, Su-Kang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8i7jap1tfjejfg6hmgcso3l403